Video game retailer GameStop is kicking off 2026 by shuttering more stores than anyone expected. On Thursday, estimates counted around 295 stores that were either already closed or in the process of ...

Abstract: A gallium nitride (GaN) two-stage comparator based on complementary logic (CL) architecture is demonstrated and systematically investigated. The comparator features monolithically integrated ...

RC and BST showed similar patient-reported and clinical outcomes after 1 year, with RC initially impacting physical function more negatively. RC was linked to better emotional and cognitive function ...

Traws Pharma Inc. (NASDAQ: TRAW) on Wednesday shared interim data from an ongoing randomized, open-label Phase 2 with ratutrelvir, an investigational oral, ritonavir-free Mpro/3CL protease inhibitor.

Physician assistant (PA)-led recovery teams for cardiac allograft yielded comparable outcomes to traditional physician-led teams, with no significant differences in rates of severe primary graft ...

BANGKOK, Dec 8 (Reuters) - Thailand has launched air strikes along its disputed border with Cambodia, its military said, after both countries accused each other of breaching a ceasefire brokered by ...

Dick's Sporting Goods will close a number of Foot Locker stores as it begins to restructure the newly acquired business. Excluding Foot Locker, Dick's saw comparable sales rise 5.7% during its fiscal ...

Our policy here at MotorTrend is to treat battery-electrics as just another powertrain choice, rather than a separate subclass of vehicles. For this three-row luxury SUV comparison, however, all the ...

Seven complaints, filed on Thursday, claim the popular chatbot encouraged dangerous discussions and led to mental breakdowns. By Kashmir Hill Four wrongful death lawsuits were filed against OpenAI on ...

While competitors are testing value menus and limited-time offers, Chipotle is taking the opposite route — betting that premium positioning will outlast consumer fatigue. It's a risky strategy in a ...

Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for cancer patients. Enoby targets bone loss in patients on hormone-based ...